Mutual of America Capital Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-33,547
| Closed | -$4.3M | – | 1359 |
|
|
2025
Q2 | $4.3M | Sell |
33,547
-974
| -3% | -$101K | 0.05% | 500 |
|
|
2025
Q1 | $3.06M | Buy |
34,521
+2,405
| +7% | +$235K | 0.04% | 650 |
|
|
2024
Q4 | $2.8M | Sell |
32,116
-28
| -0.1% | -$2.56K | 0.03% | 731 |
|
|
2024
Q3 | $2.97M | Sell |
32,144
-302
| -0.9% | -$30K | 0.03% | 728 |
|
|
2024
Q2 | $3.5M | Sell |
32,446
-1,404
| -4% | -$141K | 0.04% | 635 |
|
|
2024
Q1 | $3.21M | Sell |
33,850
-2,752
| -8% | -$236K | 0.03% | 695 |
|
|
2023
Q4 | $3.38M | Buy |
36,602
+5,204
| +17% | +$337K | 0.04% | 661 |
|
|
2023
Q3 | $1.58M | Sell |
31,398
-1,871
| -6% | -$100K | 0.02% | 954 |
|
|
2023
Q2 | $2.1M | Sell |
33,269
-2,542
| -7% | -$138K | 0.02% | 893 |
|
|
2023
Q1 | $1.61M | Sell |
35,811
-1,651
| -4% | -$74.4K | 0.02% | 966 |
|
|
2022
Q4 | $1.64M | Buy |
37,462
+511
| +1% | +$24.5K | 0.02% | 952 |
|
|
2022
Q3 | $2.44M | Sell |
36,951
-3,362
| -8% | -$216K | 0.03% | 756 |
|
|
2022
Q2 | $2.04M | Sell |
40,313
-302
| -0.7% | -$17.7K | 0.03% | 865 |
|
|
2022
Q1 | $2.59M | Sell |
40,615
-1,763
| -4% | -$127K | 0.03% | 848 |
|
|
2021
Q4 | $4.54M | Sell |
42,378
-395
| -0.9% | -$41.3K | 0.05% | 623 |
|
|
2021
Q3 | $4.4M | Sell |
42,773
-615
| -1% | -$57.3K | 0.04% | 597 |
|
|
2021
Q2 | $3.82M | Sell |
43,388
-1,867
| -4% | -$171K | 0.04% | 675 |
|
|
2021
Q1 | $4.4M | Sell |
45,255
-2,503
| -5% | -$250K | 0.05% | 593 |
|
|
2020
Q4 | $5.36M | Sell |
47,758
-1,003
| -2% | -$106K | 0.06% | 421 |
|
|
2020
Q3 | $4.52M | Buy |
48,761
+9,755
| +25% | +$751K | 0.06% | 417 |
|
|
2020
Q2 | $3.04M | Sell |
39,006
-3,237
| -8% | -$219K | 0.04% | 601 |
|
|
2020
Q1 | $2.47M | Sell |
42,243
-1,832
| -4% | -$118K | 0.04% | 600 |
|
|
2019
Q4 | $3.53M | Sell |
44,075
-300
| -0.7% | -$22.5K | 0.05% | 623 |
|
|
2019
Q3 | $3.26M | Sell |
44,375
-444
| -1% | -$38.4K | 0.05% | 628 |
|
|
2019
Q2 | $4.23M | Buy |
44,819
+28
| +0.1% | +$2.31K | 0.06% | 478 |
|
|
2019
Q1 | $3.59M | Buy |
44,791
+797
| +2% | +$58.9K | 0.05% | 573 |
|
|
2018
Q4 | $2.37M | Buy |
43,994
+20,795
| +90% | +$1.26M | 0.04% | 714 |
|
|
2018
Q3 | $1.81M | Buy |
23,199
+12,699
| +121% | +$883K | 0.03% | 938 |
|
|
2018
Q2 | $667K | Buy |
+10,500
| New | +$836K | 0.01% | 1132 |
|
Other funds holding BPMC
IA
HNB
Mutual of America Capital Management's BPMC Position: Q3 2025 in Review
Mutual of America Capital Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 33,547 shares — an estimated $4.3M sold.
Mutual of America Capital Management first reported a position in BPMC in Q2 2018 and held it in 29 quarters. The position peaked at $5.36M in Q4 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Mutual of America Capital Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Mutual of America Capital Management sold 33,547 Blueprint Medicines shares in Q3 2025, an estimated $4.3M.
- Mutual of America Capital Management first reported a position in Blueprint Medicines in Q2 2018 and held it in 29 quarters.
- Mutual of America Capital Management's Blueprint Medicines position peaked at $5.36M in Q4 2020.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Mutual of America Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.